Many viral diseases tend to become chronic – including infections with the HI virus. In persons affected, the immune response is not sufficient to eliminate the virus permanently. Scientists at the University of Bonn have now identified an immune factor which is partially responsible for this. Their results give rise to hopes for new therapeutic approaches. The work, which included researchers from the University of Cologne and the Technical University of Munich, is being published in the renowned journal "Nature Immunology."
The HI virus triggers the immunodeficiency disease AIDS. The infection has a chronic course – the immune system is not able to get rid of the pathogen. This is due among other things to the fact that the virus directly attacks and destroys certain immune cells known as helper T cells.
Prof. Dr. Joachim L. Schultze and Dr. Marc Beyer (from left) from LIMES Institute of University of Bonn.
(c) Photo: Barbara Frommann/Uni Bonn
However, many helper T cells are not affected by the virus at all. Nonetheless their function is impaired in the case of AIDS. Normally, helper T cells secrete inflammatory messengers during an infection. As a result of this chemical distress call, killer T cells (the body's own defense troops) become ready to fight and are guided to the site. By contrast, in AIDS and other chronic infections, the helper T cells remain silent. But why is that?
To answer this question, the researchers initially analyzed which genes in the silent helper cells of HIV patients are active. Result: In chronic inflammation, the immune function of the helper T cells is inhibited by various signaling pathways. These signaling pathways in turn are apparently controlled by a single molecule known as tumor necrosis factor (TNF).
This factor appears to be responsible for the weak immune response. "We investigated mice suffering from a chronic viral infection similar to an HIV infection and inactivated the TNF molecule in them," explains Dr. Marc Beyer from Life and Medical Sciences Institute (LIMES) of the University of Bonn. "As a result, the helper T cells worked normally once again. After ten days, the animals had completely eliminated the virus; they were healthy."
Misdirected protective function
Paradoxically, the tumor necrosis factor has exactly the opposite effect in acute viral attacks: It brings the immune system up to full speed and additionally ensures that cells infected with the virus commit suicide. "Therefore, in an acute infection, large quantities of TNF are formed very rapidly," says Dr. Zeinab Abdullah from the Institute of Experimental Immunology at the University Hospital Bonn. "In chronic infections, on the other hand, the body secretes small amounts of TNF over a long period of time. This appears to cause the helper T cells to shut down to some extent."
The researchers suspect that this is a protective mechanism. A prolonged strong immune reaction can in particular destroy healthy tissues as well – with life-threatening consequences. TNF could act as a type of emergency brake which prevents this. Exactly what the tumor necrosis factor does on a molecular level is still largely unknown. The scientists involved now want to examine this question in detail.
The results may establish new therapeutic options in the medium term. Thus there are drugs which inhibit the effect of TNF. These TNF blockers are used in the treatment of autoimmune diseases such as rheumatism, for example. They are to prevent defense cells from attacking the body itself. "Among other things, we want to investigate what effects these drugs have in rheumatism patients who are additionally suffering from a chronic viral infection," says Marc Beyer.
Publication: Tumor-necrosis factor impairs CD4+ T cell-mediated immunological control in chronic viral infection; Nature Immunology; DOI: 10.1038/ni.3399
Media contact information:
Dr. Marc Beyer
University of Bonn
Dr. Zeinab Abdullah
Institute of Experimental Immunology
University Hospital Bonn
Johannes Seiler | idw - Informationsdienst Wissenschaft
'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers
16.02.2018 | National University of Science and Technology MISIS
New process allows tailor-made malaria research
16.02.2018 | Eberhard Karls Universität Tübingen
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.
But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...
Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.
The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...
Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters
Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
19.02.2018 | Materials Sciences
19.02.2018 | Materials Sciences
19.02.2018 | Life Sciences